Table 1
Open in new tab

Patient characteristics. Data are mean (sd) (range)

Patientsn=15
Age (yr)63.4 (8.9) (49–81)
Weight (kg)78.1 (10.3) (62.4–90.0)
BMI26.6 (2.2) (22.7–30.7)
Preoperative NYHA class3.3 (0.5) (3–4)
LVEF (%)61.1 (11.8) (30–81)
Tobacco use: active/quit >3 months (n)4/7
High arterial pressure (n)8
Dyslipidaemia (n)11
Diabetes (n)4
Chronic renal failure (n)2
COPD (n)0
Patientsn=15
Age (yr)63.4 (8.9) (49–81)
Weight (kg)78.1 (10.3) (62.4–90.0)
BMI26.6 (2.2) (22.7–30.7)
Preoperative NYHA class3.3 (0.5) (3–4)
LVEF (%)61.1 (11.8) (30–81)
Tobacco use: active/quit >3 months (n)4/7
High arterial pressure (n)8
Dyslipidaemia (n)11
Diabetes (n)4
Chronic renal failure (n)2
COPD (n)0
Table 1
Open in new tab

Patient characteristics. Data are mean (sd) (range)

Patientsn=15
Age (yr)63.4 (8.9) (49–81)
Weight (kg)78.1 (10.3) (62.4–90.0)
BMI26.6 (2.2) (22.7–30.7)
Preoperative NYHA class3.3 (0.5) (3–4)
LVEF (%)61.1 (11.8) (30–81)
Tobacco use: active/quit >3 months (n)4/7
High arterial pressure (n)8
Dyslipidaemia (n)11
Diabetes (n)4
Chronic renal failure (n)2
COPD (n)0
Patientsn=15
Age (yr)63.4 (8.9) (49–81)
Weight (kg)78.1 (10.3) (62.4–90.0)
BMI26.6 (2.2) (22.7–30.7)
Preoperative NYHA class3.3 (0.5) (3–4)
LVEF (%)61.1 (11.8) (30–81)
Tobacco use: active/quit >3 months (n)4/7
High arterial pressure (n)8
Dyslipidaemia (n)11
Diabetes (n)4
Chronic renal failure (n)2
COPD (n)0
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close